- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 4.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 595.34K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 5.16K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $40K |
| Capex | Q1 2026 · Mar 31, 2025 | $10K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.1M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.98M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.15M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $21.22M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $15.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.63M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.01M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.91M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.27M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.09M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.53M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $21.07M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $17.63M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $30.31M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $27.02M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$18.08 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$838.43 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$18.08 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$838.43 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.12M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.8M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $285K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $162K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.26M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.57M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.93M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.88M |